+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review



The effectiveness of aripiprazole in the management of problem behaviour in people with intellectual disabilities, developmental disabilities and/or autistic spectrum disorder--a systematic review



Research in Developmental Disabilities 35(3): 711-725



The management of problem behaviours (PB) in individuals with intellectual disabilities (ID), developmental disabilities (DD) and/or autistic spectrum disorders (ASD) can be challenging. Antipsychotic medications are commonly prescribed where other strategies have failed. A systematic review (SR) was conducted to establish the research evidence for the efficacy of aripiprazole in the management of PB in adults and children with ID, DD and/or ASD. Although included studies supported the efficacy of aripiprazole for this indication, the overall quality of studies was poor. Of the 20 studies included in this systematic review there were only two randomised controlled trials (RCTs) on children with ASD and/or ID/DD, both of which were conducted by the pharmaceutical company that manufactures aripiprazole, and it is not clear whether a number of same participants were included in both RCTs. One of the RCTs was extended into an open label long term follow up, which showed that aripiprazole's efficacy lasted over 52 weeks and the adverse effects were tolerable. Four studies were open label prospective studies, 11 were retrospective case reports which included four single case reports, and two were prospective case series. Most studies reported adverse effects from aripiprazole in the form of weight gain, increased appetite, sedation, tiredness, drooling and tremor. However, aripiprazole improved serum prolactin level in some participants and overall did not show any adverse effect on QTc interval. There is a need for more carefully designed RCTs into the use of aripiprazole in the management of PB in people with ID/DD and/or ASD, which should be carried out independent of pharmaceutical companies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056315576

Download citation: RISBibTeXText

PMID: 24405794

DOI: 10.1016/j.ridd.2013.12.004


Related references

The effectiveness of methylphenidate in the management of Attention Deficit Hyperactivity Disorder (ADHD) in people with intellectual disabilities: A systematic review. Research in Developmental Disabilities 83: 217-232, 2018

Investigating low adaptive behaviour and presence of the triad of impairments characteristic of autistic spectrum disorder as indicators of risk for challenging behaviour among adults with intellectual disabilities. Journal of Intellectual Disability Research 57(2): 128-138, 2013

Efficacy of beta blockers in the management of problem behaviours in people with intellectual disabilities: a systematic review. Research in Developmental Disabilities 34(12): 4293-4303, 2013

The effectiveness of antidepressant medication in the management of behaviour problems in adults with intellectual disabilities: a systematic review. Journal of Intellectual Disability Research 51(Pt 10): 750-765, 2007

Treatment of severe problem behaviour in children with autism spectrum disorder and intellectual disabilities. International Review of Psychiatry 30(1): 96, 2018

Effectiveness of cognitive-behaviour therapy for hoarding disorder in people with mild intellectual disabilities. Research in Developmental Disabilities 47: 385-392, 2015

The effectiveness of person-centred planning for people with intellectual disabilities: A systematic review. Research in Developmental Disabilities 57: 63-84, 2016

Dialectical Behaviour Therapy [DBT] with People with Intellectual Disabilities: A Systematic Review and Narrative Analysis. Journal of Applied Research in Intellectual Disabilities 30(5): 787-804, 2017

The Effectiveness of Rehabilitation Interventions on the Employment and Functioning of People with Intellectual Disabilities: A Systematic Review. Journal of Occupational Rehabilitation 29(4): 773-802, 2019

Improving procedural fidelity of behavioural interventions for people with intellectual and developmental disabilities: A systematic review. Journal of Applied Research in Intellectual Disabilities 32(4): 762-778, 2019

Measuring symptoms of post-traumatic stress disorder in people with intellectual disabilities: the development and psychometric properties of the Impact of Event Scale-Intellectual Disabilities (IES-IDs). British Journal of Clinical Psychology 53(3): 315-332, 2014

Does engagement in meaningful occupation reduce challenging behaviour in people with intellectual disabilities? A systematic review of the literature. Journal of Intellectual Disabilities 17(1): 64-77, 2013

Social information processing in boys with autistic spectrum disorder and mild to borderline intellectual disabilities. Journal of Intellectual Disability Research 53(11): 922-931, 2009

Environmental barriers and supports to the health, function, and participation of people with developmental and intellectual disabilities: report from the State of the Science in Aging with Developmental Disabilities Conference. Disability and Health Journal 1(3): 143-149, 2011

Recent research on aetiology, development and phenomenology of self-injurious behaviour in people with intellectual disabilities: a systematic review and implications for treatment. Journal of Intellectual Disability Research 56(5): 453-475, 2012